Quote:
Originally Posted by jfman
The authorities in the USA told them in advance for their press release the figures to include. They chose not to. I doubt that's inexperience in vaccine development so much as plenty of experience in PR.
|
How so? The overall efficacy figure dropped by a mere 3 points. The efficacy figure for over-65s, which is the most important one because those are the ones it most often kills, improved by 5 points. If they actually did know those figures and wilfully chose not to use them, qui bono?